Nexstim Oyj (HE:NXTMH) — Market Cap & Net Worth
Market Cap & Net Worth: Nexstim Oyj (NXTMH)
Nexstim Oyj (HE:NXTMH) has a market capitalization of $73.20 Million (€62.61 Million) as of May 26, 2026. Listed on the HE stock exchange, this Finland-based company holds position #20534 globally and #98 in its home market, demonstrating a -5.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nexstim Oyj's stock price €8.68 by its total outstanding shares 7213387 (7.21 Million). Analyse Nexstim Oyj cash flow conversion to see how efficiently the company converts income to cash.
Nexstim Oyj Market Cap History: 2015 to 2026
Nexstim Oyj's market capitalization history from 2015 to 2026. Data shows change from $5.13 Billion to $73.20 Million (-32.41% CAGR).
Index Memberships
Nexstim Oyj is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Finland EUR PI
FNFIEURPI
|
$1.76 Billion | 4.16% | #6 of 25 |
Weight: Nexstim Oyj's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nexstim Oyj Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nexstim Oyj's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.63x
Nexstim Oyj's market cap is 7.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $5.13 Billion | $2.53 Million | -$9.83 Million | 2030.58x | N/A |
| 2016 | $126.34 Million | $2.48 Million | -$6.73 Million | 50.89x | N/A |
| 2017 | $218.51 Million | $2.65 Million | -$7.33 Million | 82.60x | N/A |
| 2018 | $15.92 Million | $2.67 Million | -$6.15 Million | 5.96x | N/A |
| 2019 | $18.45 Million | $3.35 Million | -$6.78 Million | 5.51x | N/A |
| 2020 | $64.57 Million | $4.11 Million | -$4.12 Million | 15.70x | N/A |
| 2021 | $40.31 Million | $6.40 Million | -$832.11K | 6.30x | N/A |
| 2022 | $34.66 Million | $9.53 Million | $1.31 Million | 3.64x | 26.52x |
| 2023 | $24.46 Million | $7.25 Million | -$1.33 Million | 3.38x | N/A |
| 2024 | $66.62 Million | $8.74 Million | -$892.29K | 7.63x | N/A |
Competitor Companies of NXTMH by Market Capitalization
Companies near Nexstim Oyj in the global market cap rankings as of May 26, 2026.
Key companies related to Nexstim Oyj by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #152 globally with a market cap of $151.99 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #196 globally with a market cap of $121.11 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #235 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #259 globally with a market cap of $97.77 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #152 | Abbott Laboratories | NYSE:ABT | $151.99 Billion | $87.41 |
| #196 | Stryker Corporation | NYSE:SYK | $121.11 Billion | $316.48 |
| #235 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #259 | Medtronic PLC | NYSE:MDT | $97.77 Billion | $78.60 |
Nexstim Oyj Historical Marketcap From 2015 to 2026
Between 2015 and today, Nexstim Oyj's market cap moved from $5.13 Billion to $ 73.20 Million, with a yearly change of -32.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €73.20 Million | -38.87% |
| 2025 | €119.75 Million | +79.75% |
| 2024 | €66.62 Million | +172.41% |
| 2023 | €24.46 Million | -29.44% |
| 2022 | €34.66 Million | -14.02% |
| 2021 | €40.31 Million | -37.58% |
| 2020 | €64.57 Million | +250.09% |
| 2019 | €18.45 Million | +15.87% |
| 2018 | €15.92 Million | -92.72% |
| 2017 | €218.51 Million | +72.96% |
| 2016 | €126.34 Million | -97.54% |
| 2015 | €5.13 Billion | -- |
End of Day Market Cap According to Different Sources
On May 25th, 2026 the market cap of Nexstim Oyj was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $73.20 Million USD |
| MoneyControl | $73.20 Million USD |
| MarketWatch | $73.20 Million USD |
| marketcap.company | $73.20 Million USD |
| Reuters | $73.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nexstim Oyj
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provi… Read more